全文获取类型
收费全文 | 14893篇 |
免费 | 781篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 130篇 |
儿科学 | 450篇 |
妇产科学 | 2033篇 |
基础医学 | 2138篇 |
口腔科学 | 466篇 |
临床医学 | 1654篇 |
内科学 | 2678篇 |
皮肤病学 | 238篇 |
神经病学 | 997篇 |
特种医学 | 649篇 |
外科学 | 1623篇 |
综合类 | 104篇 |
一般理论 | 1篇 |
预防医学 | 1236篇 |
眼科学 | 236篇 |
药学 | 571篇 |
中国医学 | 56篇 |
肿瘤学 | 451篇 |
出版年
2021年 | 181篇 |
2020年 | 103篇 |
2019年 | 179篇 |
2018年 | 235篇 |
2017年 | 186篇 |
2016年 | 162篇 |
2015年 | 242篇 |
2014年 | 342篇 |
2013年 | 581篇 |
2012年 | 565篇 |
2011年 | 599篇 |
2010年 | 416篇 |
2009年 | 542篇 |
2008年 | 612篇 |
2007年 | 562篇 |
2006年 | 570篇 |
2005年 | 583篇 |
2004年 | 543篇 |
2003年 | 512篇 |
2002年 | 474篇 |
2001年 | 196篇 |
2000年 | 169篇 |
1999年 | 409篇 |
1998年 | 373篇 |
1997年 | 406篇 |
1996年 | 416篇 |
1995年 | 364篇 |
1994年 | 315篇 |
1993年 | 224篇 |
1992年 | 255篇 |
1991年 | 260篇 |
1990年 | 203篇 |
1989年 | 193篇 |
1988年 | 181篇 |
1987年 | 149篇 |
1986年 | 188篇 |
1985年 | 148篇 |
1984年 | 131篇 |
1983年 | 159篇 |
1982年 | 106篇 |
1981年 | 94篇 |
1980年 | 111篇 |
1979年 | 107篇 |
1978年 | 73篇 |
1977年 | 105篇 |
1976年 | 105篇 |
1975年 | 105篇 |
1974年 | 76篇 |
1973年 | 80篇 |
1922年 | 60篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
981.
982.
983.
Huppertz A Balzer T Blakeborough A Breuer J Giovagnoni A Heinz-Peer G Laniado M Manfredi RM Mathieu DG Mueller D Reimer P Robinson PJ Strotzer M Taupitz M Vogl TJ;European EOB Study Group 《Radiology》2004,230(1):266-275
PURPOSE: To evaluate the safety and efficacy of gadoxetic acid disodium-enhanced magnetic resonance (MR) imaging for the detection of focal liver lesions, with results of histopathologic examination and/or intraoperative ultrasonography used as a standard of reference. MATERIALS AND METHODS: One hundred sixty-nine patients who were known to have or suspected of having focal liver lesions and were scheduled for liver surgery were included in this study. Results in 131 patients could be included in the efficacy analysis. MR imaging was performed before and immediately and 20 minutes after bolus injection of 0.025 mmol/kg of the liver-specific hepatobiliary contrast agent gadoxetic acid. T1-weighted gradient-echo (with and without fat saturation and including dynamic data sets) and T2-weighted fast spin-echo/turbo spin-echo sequences were performed. All images were evaluated on site and by three independent and blinded off-site reviewers. Lesion matching based on the standard-of-reference results was performed. Differences in lesion detection with precontrast and with postcontrast MR images were assessed with the two-sided Wilcoxon signed rank test. RESULTS: Gadoxetic acid was well tolerated. In the on-site review, the number of patients in whom all lesions were correctly matched increased from 89 of 129 patients at precontrast MR imaging to 103 of 129 patients at postcontrast MR imaging. In the off-site evaluation, the number of patients in whom all lesions were correctly matched and the corresponding sensitivity values increased from 72 (55.8%), 68 (52.7%), and 66 (51.2%) with the precontrast images to 88 (68.2%), 69 (53.5%), and 76 (58.9%) with the postcontrast images for readers 1, 2, and 3, respectively. Two of the three blinded readers showed a statistically significant difference in lesion detection between precontrast and postcontrast MR imaging (P <.001 and P =.008). A large number of additionally correctly detected and localized lesions were smaller than 1 cm. CONCLUSION: MR imaging with gadoxetic acid is safe and improves lesion detection and localization. 相似文献
984.
Piesse C Cadel S Gouzy-Darmon C Jeanny JC Carrière V Goidin D Jonet L Gourdji D Cohen P Foulon T 《Experimental eye research》2004,79(5):639-648
Aminopeptidase B (Ap-B), a ubiquitous enzyme, catalyses the amino-terminal cleavage of basic residues of peptide or protein substrates, indicating a role in precursor processing. The physiological function of Ap-B still remains an open question, even though its activity suggests that it could be involved in inflammatory processes and proliferation of tumor cells. This study was conducted to determine the expression of Ap-B in the developing and adult retina as a path to envisage physiological roles of Ap-B. RT-PCR and in situ hybridization were used to detect expression of Ap-B mRNA and activity tests, Western blotting and immunofluorescence microscopy were performed to identify and localize the enzyme in the rat retina. These biochemical and morphological methods show that Ap-B is expressed in the retina from embryo to adult. Expression level is restricted to specific layers (pigmented epithelium, outer and inner plexiform layers and ganglion cell layer) and is developmentally regulated. Moreover, a preliminary analysis indicates that Ap-B, the glucose transporter GLUT3 and choline acetyltransferase (ChAT) share a similar expression pattern in retina. Altogether, Ap-B appears predominantly expressed in neuronal cells lying in retinal layers containing neuritic extensions and synaptic junctions. Such expression is up-regulated during ontogenesis allowing to hypothesized that Ap-B participates in processes accompanying retinal neuronal cell differentiation. 相似文献
985.
986.
Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens 总被引:7,自引:0,他引:7
Francois A Chevalier C Delmas B Eterradossi N Toquin D Rivallan G Langlois P 《Vaccine》2004,22(17-18):2351-2360
To develop a CELO virus vector that can induce protection against infectious bursal disease, CELO viruses expressing the host-protective antigen VP2 of infectious bursal disease virus (IBDV) were constructed. In the engineered recombinants, the VP2 gene (the 441-first codons of the IBDA polyprotein) was placed under the control of the CMV promoter. Two positions in the CELO genome were chosen to insert the VP2 expression cassette. The recombinants were found apathogenic, when inoculated by different routes and even at high doses (up to 10(8) per animal). Chickens vaccinated oro-nasally with these different recombinants and challenged with very virulent IBDV were found to be poorly protected. In contrast, when inoculated with one or two (subcutaneous or intradermic) injections of CELOa-VP2, the chickens showed no clinical signs and no mortality after challenge. In the vaccinated chickens, the titers of neutralization antibody reached 7-9 values, showing that protection could be explained by the induction of a sufficient humoral response. After challenge, the weight ratio Bursa of Fabricius/body was about 2.5 per thousand, a value similar to that obtained with the commercial Bur706 vaccine. However, histological lesions in the Bursa of Fabricius were observed, showing that a complete protection was not totally achieved. Contact transmission was evidenced. Protection was also obtained when inoculation of CELOa-VP2 was carried out in ovo. Prime-boost strategies were also tested with the CELOa-VP2 vector used in association with the purified VP2 antigen, or DNA encoding VP2 or a CELO vector expressing chicken myeloid growth factor (cMGF). None of these regimens were shown to substantially increase the level of protection when compared to double CELOa-VP2 inoculations. These results indicate that CELO-based vectors are useful to safely induce a strong protective immunity against vvIBDV in chickens. 相似文献
987.
988.
989.
Humbey O Aubin F Cairey-Remonnay S Riethmuller D Pretet JL Fest T Seilles E Mougin C 《European journal of obstetrics, gynecology, and reproductive biology》2002,103(1):60-64
OBJECTIVE: To investigate the codon 72 TP53 polymorphism in women from eastern France with normal or abnormal cervical cytology.STUDY DESIGN: We analyzed the TP53 allele distribution by denaturant gradient gel electrophoresis assay and the human papillomaviruses (HPV) infection in 138 cervical smears: 50 normal, 20 atypical squamous cells of undetermined significance, 40 low grade squamous intraepithelial lesions, 28 high grade squamous intraepithelial lesions.RESULTS: The viral DNA prevalence increased with cytological abnormalities. The rates of arginine (Arg) and proline (Pro) homozygosity and Arg/Pro heterozygosity were 49, 0.72, and 51%, respectively. No association was found between HPV status and TP53 polymorphism. No differences were observed in the frequency of the TP53 genotypes according to cytology.CONCLUSION: The TP53 Arg/Arg genotype does not appear to represent a risk factor in the progression of HPV associated cervical lesions. We were not able to confirm that the TP53 genotype increases the susceptibility to be infected by HPV or to develop HGSIL, and a fortiori invasive carcinoma of the cervix. 相似文献
990.
Baguley BC 《BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy》2002,16(2):97-103
The problems of why metastatic cancers develop pleiotropic resistance to all available therapies, and how this might be countered, are the most pressing in cancer chemotherapy. It is likely that such resistance involves a combination of mechanisms including changes in drug transport/drug targets, reduction in the degree of drug-induced apoptosis/cell loss, and increased rate of tumour repopulation following therapy. Current research must consider not only which mechanisms contribute, eventually relating this to individual patients with cancer, but also what strategies might be utilised to counter each of the important resistance mechanisms. A considerable amount of work has been devoted to the development of inhibitors of membrane-associated transport proteins such as P-glycoprotein, which mediate drug efflux. This work is now being complemented by approaches that target cell death pathways such as those mediated by release of mitochondrial proteins and by activation of surface receptors such as Fas. Rapid progress has been made in developing small-molecular-weight drugs that influence the rate of apoptosis, for instance by binding to the bcl-2 family of proteins regulating mitochondrial permeability. Antisense approaches aimed at reducing bcl-2 expression, and thus increasing the rate of cell death, are also showing promise. Modification of repopulation kinetics provides a further approach but has not received as much attention as other aspects of tumour resistance. New therapeutic approaches will have to be complemented by improved diagnostic tests to evaluate the contributions of different resistance mechanisms in individual patients with cancer. 相似文献